- Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025
- Tom Arnold Appointed CEO of ViCentra
- Dr. Samuel A. Joseph Jr. Named Clinical Assistant Professor of Orthopaedic Surgery at HCA/USF Orthopaedic Program
- Fosun Pharma Received NMPA Approval for Wan Ti Le | (Tenapanor Hydrochloride Tablets)
- EPO Grants Key CRISPR Patent to ERS Genomics CVC Portfolio
- Birgitte Volck Appointed Non-Executive Director at OMass Therapeutics
- DT Research Extends Comprehensive Medical Computing Line with DT514 All-in-One Computers
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
Kidd & Company, LLC Exits NextPhase Medical Devices, LLC
Kidd & Company advises NextPhase is a class II and III medical device contract manufacturer of complex electromechanical devices, active implantable devices and single use disposables in North America. It provides design and engineering, manufacturing and assembly, quality and regulatory, and supply chain and logistics management services enabling its customers to bring low-to-medium volume complex medical devices to market.
CMS Establishes HCPCS code for Ultromics EchoGo ® Heart Failure, Accelerating Access to Precision HFpEF Detection
Ultromics EchoGo ® Heart Failure is the first US Food and Drug Administration (FDA) cleared platform for detecting Heart Failure with Preserved Ejection Fraction (HFpEF), using a single view of an echocardiogram. The platform has the potential to catch disease earlier and get more patients on the pathway to treatment.
CPR Therapeutics Inc. Receives Three Patents In One Week For Innovations In Cardiopulmonary Resuscitation Technology
Norman Paradis MD, CPR Therapeutics Founder and CEO stated: “Receiving all three patents in one week is a wonderful coincidence that highlights the breadth of our innovation. We already knew that our existing patent portfolio was strong and provided a sound foundation for our future commercial efforts. Now it is even stronger. I believe any one of these patents could justifiably be called a breakthrough invention in and of itself.”
Medical Syringe: The Alternatives With High-Quality Materials
Medical syringes are indispensable tools in healthcare settings, facilitating the safe and precise administration of medications, vaccines, and other substances. Traditionally made from glass or
Clinical Trials
Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea
The nausea study revealed how nausea can affect daily life in many unpleasant ways. More than 18% of respondents reported that their nausea actively hindered their ability to travel, while some could not socialize (3.2%) or even work (2.9%). These findings highlight how nausea extends beyond mere inconvenience for a large majority of the U.S. population.
Akura Medical Announces Successful First-in-Human Use of its High Performance Mechanical Thrombectomy Platform
While the use of mechanical thrombectomy devices has been increasing, current options are procedurally complex, use large bore devices, are frequently inefficient, and have difficulty reaching the target anatomy.
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome
Adimune™ has signed a clinical trial agreement with Mayo Clinic to advance clinical studies targeting autoimmune diseases of the central nervous system (“CNS”) with the initial focus on the rare, but debilitating, autoimmune disease Stiff Person Syndrome. Adimune was founded earlier this year to lead Aditxt’s immune modulation therapeutic programs.
Biotechnology News
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Digital Pathology Reaches an Inflection Point as AI Targets Workflow Gaps | By Yair Rivenson, PhD Founder and CEO, Pictor Labs
Laboratories face mounting pressure to modernize imaging, preserve tissue, and reduce sequencing failures as adoption continues to move at a glacial pace
FIZE Medical Launches 5,000-Patient Retrospective Study to Further Establish the benefits of using FIZE kUO in managing ICU patients’ Hemodynamic status
By continuously capturing renal function patterns, the study aims to demonstrate how FIZE kUO® can provide data for early signs of instability that are often missed by intermittent measurements
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Market Reports